Niagen Bioscience (NAGE) Cash & Equivalents Growth (1y) (2016 - 2026)
Niagen Bioscience (NAGE) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | 19.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.66% |
| Dec 31, 2025 | 45.07% |
| Sep 30, 2025 | 98.44% |
| Jun 30, 2025 | 116.87% |
| Mar 31, 2025 | 101.76% |
| Dec 31, 2024 | 63.44% |
| Sep 30, 2024 | 21.01% |
| Jun 30, 2024 | 5.60% |
| Mar 31, 2024 | 19.12% |
| Dec 31, 2023 | 33.68% |
| Sep 30, 2023 | 101.88% |
| Jun 30, 2023 | 54.67% |
| Mar 31, 2023 | 10.23% |
| Dec 31, 2022 | -27.56% |
| Sep 30, 2022 | -59.94% |
| Jun 30, 2022 | -55.98% |
| Mar 31, 2022 | -53.04% |
| Dec 31, 2021 | 69.01% |
| Jun 30, 2021 | 105.28% |
| Mar 31, 2021 | 228.48% |